72 related articles for article (PubMed ID: 16203382)
1. Anti-social personality disorder and response to methadone maintenance treatment.
Darke S; Finlay-Jones R; Kaye S; Blatt T
Drug Alcohol Rev; 1996 Sep; 15(3):271-6. PubMed ID: 16203382
[TBL] [Abstract][Full Text] [Related]
2. The relationship of conduct disorder to attempted suicide and drug use history among methadone maintenance patients.
Darke S; Ross J; Lynskey M
Drug Alcohol Rev; 2003 Mar; 22(1):21-5. PubMed ID: 12745355
[TBL] [Abstract][Full Text] [Related]
3. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
Bloor M; McIntosh J; McKeganey N; Robertson M
Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
[TBL] [Abstract][Full Text] [Related]
4. Personality disorder and drug use: a review.
Seivewright N; Daly C
Drug Alcohol Rev; 1997 Sep; 16(3):235-50. PubMed ID: 16203433
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients.
Darke S; Hall W; Swift W
Drug Alcohol Depend; 1994 Feb; 34(3):253-7. PubMed ID: 8033764
[TBL] [Abstract][Full Text] [Related]
6. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Ngo HT; Tait RJ; Hulse GK
Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of interim methadone maintenance.
Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
[TBL] [Abstract][Full Text] [Related]
9. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
10. Is antisocial personality disorder continuous or categorical? A taxometric analysis.
Marcus DK; Lilienfeld SO; Edens JF; Poythress NG
Psychol Med; 2006 Nov; 36(11):1571-81. PubMed ID: 16836795
[TBL] [Abstract][Full Text] [Related]
11. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
[TBL] [Abstract][Full Text] [Related]
12. Effects of comorbid psychopathy on criminal offending and emotion processing in male offenders with antisocial personality disorder.
Kosson DS; Lorenz AR; Newman JP
J Abnorm Psychol; 2006 Nov; 115(4):798-806. PubMed ID: 17100537
[TBL] [Abstract][Full Text] [Related]
13. Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment.
van der Zanden BP; Dijkgraaf MG; Blanken P; van Ree JM; van den Brink W
Drug Alcohol Depend; 2007 Jan; 86(1):84-90. PubMed ID: 16806740
[TBL] [Abstract][Full Text] [Related]
14. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
15. Antisocial personality disorder in Turkish substance dependent patients and its relationship with anxiety, depression and a history of childhood abuse.
Evren C; Kural S; Erkiran M
Isr J Psychiatry Relat Sci; 2006; 43(1):40-6. PubMed ID: 16910384
[TBL] [Abstract][Full Text] [Related]
16. Drug use and HIV/AIDS in China.
Liu Z; Lian Z; Zhao C
Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
[TBL] [Abstract][Full Text] [Related]
17. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
[TBL] [Abstract][Full Text] [Related]
18. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
[TBL] [Abstract][Full Text] [Related]
19. Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy.
Gill K; Nolimal D; Crowley TJ
Drug Alcohol Depend; 1992 Aug; 30(3):247-52. PubMed ID: 1396106
[TBL] [Abstract][Full Text] [Related]
20. A comparison of residential heroin detoxification patients and methadone maintenance patients.
Caplehorn JR; Saunders JB
Drug Alcohol Rev; 1993; 12(3):259-63. PubMed ID: 16840283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
